Publication: Lack of IL7Rα expression in T cells is a hallmark of T-cell immunodeficiency in Schimke immuno-osseous dysplasia (SIOD)
| dc.contributor.author | Sanyal, Mrinmoy (55506354600) | |
| dc.contributor.author | Morimoto, Marie (54400133600) | |
| dc.contributor.author | Baradaran-Heravi, Alireza (24576318700) | |
| dc.contributor.author | Choi, Kunho (7403949485) | |
| dc.contributor.author | Kambham, Neeraja (6603340119) | |
| dc.contributor.author | Jensen, Kent (56316571300) | |
| dc.contributor.author | Dutt, Suparna (8323822500) | |
| dc.contributor.author | Dionis-Petersen, Kira Y. (56925380200) | |
| dc.contributor.author | Liu, Lan Xiang (56923886400) | |
| dc.contributor.author | Felix, Katie (56924910800) | |
| dc.contributor.author | Mayfield, Christy (36480369200) | |
| dc.contributor.author | Dekel, Benjamin (7004279520) | |
| dc.contributor.author | Bokenkamp, Arend (7003677203) | |
| dc.contributor.author | Fryssira, Helen (6602617953) | |
| dc.contributor.author | Guillen-Navarro, Encarna (14028300200) | |
| dc.contributor.author | Lama, Giuliana (55298071600) | |
| dc.contributor.author | Brugnara, Milena (22984429500) | |
| dc.contributor.author | Lücke, Thomas (7004154235) | |
| dc.contributor.author | Olney, Ann Haskins (57216387044) | |
| dc.contributor.author | Hunley, Tracy E. (6602466725) | |
| dc.date.accessioned | 2025-06-12T19:12:00Z | |
| dc.date.available | 2025-06-12T19:12:00Z | |
| dc.date.issued | 2015 | |
| dc.description.abstract | Schimke immuno-osseous dysplasia (SIOD) is an autosomal recessive, fatal childhood disorder associated with skeletal dysplasia, renal dysfunction, and T-cell immunodeficiency. This disease is linked to biallelic loss-of-function mutations of the SMARCAL1 gene. Although recurrent infection, due to T-cell deficiency, is a leading cause of morbidity and mortality, the etiology of the T-cell immunodeficiency is unclear. Here, we demonstrate that the T cells of SIOD patients have undetectable levels of protein and mRNA for the IL-7 receptor alpha chain (IL7Rα) and are unresponsive to stimulation with IL-7, indicating a loss of functional receptor. No pathogenic mutations were detected in the exons of IL7R in these patients; however, CpG sites in the IL7R promoter were hypermethylated in SIOD T cells. We propose therefore that the lack of IL7Rα expression, associated with hypermethylation of the IL7R promoter, in T cells and possibly their earlier progenitors, restricts T-cell development in SIOD patients. © 2015 Elsevier Inc. | |
| dc.identifier.uri | https://doi.org/10.1016/j.clim.2015.10.005 | |
| dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84945308414&doi=10.1016%2fj.clim.2015.10.005&partnerID=40&md5=83d3bed24abbae8346e00e758518dcfd | |
| dc.identifier.uri | https://remedy.med.bg.ac.rs/handle/123456789/8014 | |
| dc.subject | CD127 | |
| dc.subject | CpG | |
| dc.subject | IL7Rα | |
| dc.subject | Promoter DNA methylation | |
| dc.subject | SIOD | |
| dc.subject | T-cell immunodeficiency | |
| dc.title | Lack of IL7Rα expression in T cells is a hallmark of T-cell immunodeficiency in Schimke immuno-osseous dysplasia (SIOD) | |
| dspace.entity.type | Publication | |
